Hospira Inc
General
Total Cases140
Active Cases11
Patents308
Ratings
Experience
Grade
Trend
DCT
L5
A
PTAB
L5
A
CAFC
L5
E
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 08/28/23 | ORAL ORDER. The Court believes that Defendant's Motion to Redact Portions of the May 17, 2022 Teleconference Transcript (D.I. 964 ) is moot and intends therefore to deny the motion. If Defendant disagrees, it shall file no later than September 6, 2023 a letter explaining why the motion is not moot and why denying the motion would cause significant harm to Defendant. Ordered by Judge Colm F. Connolly on 8/28/2023. (kmd) (Entered: 08/28/2023) | |
| 08/17/23 | SO ORDERED, re 998 Stipulation to discharge bond re 995 Letter, filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Signed by Judge Colm F. Connolly on 8/17/2023. (kmd) (Entered: 08/17/2023) | |
| 08/17/23 | STIPULATION to discharge bond re 995 Letter by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) (Entered: 08/17/2023) | |
| 05/31/23 | Notice re Attorney Appearance - Requesting Removal of Co-Counsel | |
| 05/31/23 | NOTICE requesting Clerk to remove Elizabeth M. Flanagan and W. Chad Shear as co-counsel. Reason for request: No longer at firm. (Oakes, Robert) (Entered: 05/31/2023) | |
| 05/10/23 | MANDATE of USCA as to 956 Notice of Appeal (Federal Circuit) filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. USCA Decision: AFFIRMED. (Attachments: # 1 Opinion, # 2 Judgment)(nmf) (Entered: 05/10/2023) | |
| 11/01/22 | [SEALED] Letter to Honorable Colm F. Connolly from Robert M. Oakes regarding bond. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Oakes, Robert) (Entered: 11/01/2022) | |
| 11/01/22 | [SEALED] Letter to Honorable Colm F. Connolly from Robert M. Oakes regarding bond. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Oakes, Robert) (Entered: 11/01/2022) | |
| 10/04/22 | REDACTED VERSION of 992 Letter by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # 1 Redacted bond)(Oakes, Robert) (Entered: 10/04/2022) | |
| 09/27/22 | REDACTED VERSION of 987 Letter by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Attachments: # 1 Exhibit A)(Oakes, Robert) (Entered: 09/27/2022) |